Either way, CVC indicates the imbalance between promoting (advanced age, dialysis duration, diabetes, malnutrition, and minera metabolism disorder) and resisting factors (fetuin-A, pyrophosphate, and adenosine) in MHD patients [17]. This evidence concerns the gene AHSG and Other metabolic disease.